Oxytocin receptor knockout prairie voles generated by CRISPR/Cas9 editing show reduced preference for social novelty and exaggerated repetitive behaviors.
Animals
Animals, Genetically Modified
Anxiety
/ genetics
Arvicolinae
/ genetics
Autistic Disorder
/ genetics
CRISPR-Cas Systems
/ genetics
Exploratory Behavior
/ physiology
Female
Gene Editing
/ methods
Gene Knockdown Techniques
Male
Mice
Obsessive Behavior
/ genetics
Oxytocin
/ metabolism
Receptors, Oxytocin
/ genetics
Social Behavior
Autism spectrum disorder
CRISPR/Cas9
Genome editing
Non-traditional models
Oxytocin receptor
Prairie voles
Social behavior
Social novelty preference
Journal
Hormones and behavior
ISSN: 1095-6867
Titre abrégé: Horm Behav
Pays: United States
ID NLM: 0217764
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
10
08
2018
revised:
19
10
2018
accepted:
22
10
2018
pubmed:
5
2
2019
medline:
6
2
2020
entrez:
5
2
2019
Statut:
ppublish
Résumé
Behavioral neuroendocrinology has benefited tremendously from the use of a wide range of model organisms that are ideally suited for particular questions. However, in recent years the ability to manipulate the genomes of laboratory strains of mice has led to rapid advances in our understanding of the role of specific genes, circuits and neural populations in regulating behavior. While genome manipulation in mice has been a boon for behavioral neuroscience, the intensive focus on the mouse restricts the diversity in behavioral questions that can be investigated using state-of-the-art techniques. The CRISPR/Cas9 system has great potential for efficiently generating mutants in non-traditional animal models and consequently to reinvigorate comparative behavioral neuroendocrinology. Here we describe the efficient generation of oxytocin receptor (Oxtr) mutant prairie voles (Microtus ochrogaster) using the CRISPR/Cas9 system, and describe initial behavioral phenotyping focusing on behaviors relevant to autism. Oxtr mutant male voles show no disruption in pup ultrasonic vocalization, anxiety as measured by the open field test, alloparental behavior, or sociability in the three chamber test. Mutants did however show a modest elevation in repetitive behavior in the marble burying test, and an impairment in preference for social novelty. The ability to efficiently generate targeted mutations in the prairie vole genome will greatly expand the utility of this model organism for discovering the genetic and circuit mechanisms underlying complex social behaviors, and serves as a proof of principle for expanding this approach to other non-traditional model organisms.
Identifiants
pubmed: 30713102
pii: S0018-506X(18)30326-X
doi: 10.1016/j.yhbeh.2018.10.011
pmc: PMC6506400
mid: NIHMS1512017
pii:
doi:
Substances chimiques
Receptors, Oxytocin
0
Oxytocin
50-56-6
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
60-69Subventions
Organisme : NIH HHS
ID : P51 OD011132
Pays : United States
Organisme : NIMH NIH HHS
ID : P50 MH100023
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH096983
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH114151
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH112788
Pays : United States
Informations de copyright
Copyright © 2018 Elsevier Inc. All rights reserved.
Références
Nat Biotechnol. 2013 Aug;31(8):684-6
pubmed: 23929337
Neuropsychopharmacology. 2015 Jul;40(8):1856-65
pubmed: 25652247
Science. 2015 Feb 20;347(6224):825-6
pubmed: 25700501
Front Neuroendocrinol. 2011 Jan;32(1):53-69
pubmed: 20688099
Dev Neurobiol. 2017 Feb;77(2):214-232
pubmed: 27804277
Integr Zool. 2018 Nov;13(6):616-633
pubmed: 29851228
Horm Behav. 2004 May;45(5):354-61
pubmed: 15109910
Horm Behav. 2012 Mar;61(3):436-44
pubmed: 22100185
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4389-94
pubmed: 20160081
Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19144-9
pubmed: 19858480
Trends Neurosci. 2010 Feb;33(2):103-9
pubmed: 20005580
Science. 2017 Oct 27;358(6362):466-469
pubmed: 29074765
Psychopharmacology (Berl). 2009 Jun;204(2):361-73
pubmed: 19189082
Nat Rev Neurosci. 2010 Jul;11(7):490-502
pubmed: 20559336
Methods Mol Biol. 2010;649:247-56
pubmed: 20680839
Nature. 2017 Jun 8;546(7657):297-301
pubmed: 28562592
Nat Neurosci. 2004 Oct;7(10):1048-54
pubmed: 15452576
Horm Behav. 2017 Jan;87:16-24
pubmed: 27793769
Genes Brain Behav. 2011 Feb;10(1):17-27
pubmed: 20579107
Nature. 2018 Apr;556(7701):326-331
pubmed: 29643503
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16096-101
pubmed: 16249339
Behav Brain Res. 2008 Mar 5;187(2):371-8
pubmed: 18005969
Cell. 2013 May 9;153(4):910-8
pubmed: 23643243
Bioinformatics. 2014 Apr 15;30(8):1180-1182
pubmed: 24389662
Nat Rev Neurosci. 2018 Nov;19(11):643-654
pubmed: 30301953
Nat Neurosci. 2006 Jan;9(1):133-9
pubmed: 16327783
Nature. 2012 Feb 15;482(7385):331-8
pubmed: 22337052
Trends Neurosci. 2015 May;38(5):273-8
pubmed: 25800324
Genome Biol. 2015 Apr 29;16:87
pubmed: 25924609
Cell Res. 2015 Dec;25(12):1372-5
pubmed: 26565559
ACS Chem Neurosci. 2017 Dec 20;8(12):2683-2697
pubmed: 28945961
PLoS Genet. 2015 Feb 26;11(2):e1005009
pubmed: 25719383
Neurosci Biobehav Rev. 2017 May;76(Pt A):87-98
pubmed: 28434591
Science. 2016 Jan 22;351(6271):375-8
pubmed: 26798013
Science. 2007 Mar 23;315(5819):1709-12
pubmed: 17379808
Biochem Biophys Res Commun. 2015 Aug 7;463(4):907-11
pubmed: 26071353
Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):5981-5
pubmed: 1321430
Psychoneuroendocrinology. 2016 Feb;64:66-78
pubmed: 26615473
Science. 2008 Nov 7;322(5903):900-4
pubmed: 18988842
Genes Brain Behav. 2004 Oct;3(5):303-14
pubmed: 15344923
Front Behav Neurosci. 2018 Mar 19;12:50
pubmed: 29615879
Genes Brain Behav. 2013 Jun;12(4):397-404
pubmed: 23521753
Nat Biotechnol. 2013 Mar;31(3):230-2
pubmed: 23360966
Biol Psychiatry. 2011 May 1;69(9):875-82
pubmed: 21306704
Biochem Biophys Res Commun. 2016 Apr 1;472(2):319-23
pubmed: 26926566
Neuropeptides. 2007 Jun;41(3):145-63
pubmed: 17420046
J Neurosci. 2001 Oct 15;21(20):8278-85
pubmed: 11588199
Curr Top Behav Neurosci. 2018;35:97-117
pubmed: 28812266
J Mol Cell Biol. 2015 Dec;7(6):580-3
pubmed: 26459633
Biol Psychiatry. 2014 Aug 15;76(4):281-8
pubmed: 24183103
Horm Behav. 2016 Mar;79:8-17
pubmed: 26643557
J Med Chem. 1994 Mar 4;37(5):565-71
pubmed: 8126695
Sci Rep. 2013 Nov 27;3:3355
pubmed: 24284873
Cell Res. 2014 Mar;24(3):372-5
pubmed: 24481528
Behav Brain Res. 2006 Jan 6;166(1):93-100
pubmed: 16154649
Neuropharmacology. 2018 Jan;128:22-32
pubmed: 28888943
Soc Neurosci. 2015;10(5):561-70
pubmed: 25874849
Int J Psychophysiol. 2019 Feb;136:54-63
pubmed: 29330007
Neuropsychopharmacology. 2009 May;34(6):1406-15
pubmed: 18923404
Transl Psychiatry. 2015 Jul 21;5:e606
pubmed: 26196439
J Neurosci. 2009 Feb 4;29(5):1312-8
pubmed: 19193878
Science. 2013 Feb 15;339(6121):823-6
pubmed: 23287722
Nature. 2011 Mar 31;471(7340):602-7
pubmed: 21455174
Physiol Behav. 2016 Oct 1;164(Pt A):249-58
pubmed: 27306084
Nat Biotechnol. 2013 Aug;31(8):681-3
pubmed: 23929336
J Vis Exp. 2013 Dec 24;(82):50978
pubmed: 24429507
Curr Opin Behav Sci. 2015 Jun;3:38-44
pubmed: 26146650
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
Nat Methods. 2012 Oct;9(10):1021-9
pubmed: 22983457
Neuroscience. 2006 Aug 25;141(2):559-568
pubmed: 16725274
Prog Brain Res. 2008;170:473-512
pubmed: 18655903
Dev Psychobiol. 2005 Sep;47(2):166-78
pubmed: 16136562